Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gilliver
David Gilliver, Victoria NZ
| Patent application number | Description | Published |
|---|---|---|
| 20090217929 | Delivery of Respiratory Therapy - An air delivery system for providing a supply of air from a source of air at positive pressure to an interfacing structure located at the entrance to the airways of a patient includes a manifold adapted to connect with the supply of positive air pressure and at least one tube connected to the manifold and adapted to deliver the supply of air to the interfacing structure. Each tube is structured to allow movement between an open phase in which the tube allows the passage of air and a collapsed phase in which the tube is collapsed. Each tube is structured such that weight of a typical patient's head against bedding apparel is sufficient to collapse the tube from the open phase to the collapsed phase. | 09-03-2009 |
David Gilliver, South Windsor AU
| Patent application number | Description | Published |
|---|---|---|
| 20110167972 | FOAM CUTTING APPARATUS AND METHOD - The present invention comprises a protrusion cutting apparatus ( | 07-14-2011 |
Lissa Gilliver, Auckland NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110213134 | Synthetic membrane anchors - The invention relates to synthetic molecules that spontaneously and stably incorporate into lipid by-layers, including cell membranes. Particularly, although not exclusively, the invention relates to the use of these molecules as synthetic membrane anchors or synthetic molecule constructs to effect qualitative and quantitative changes in the expression of cell surface antigens. | 09-01-2011 |
Lissa Gwyneth Gilliver, Auckland NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110312005 | Enzymatic modification of cell-surface H antigen by glycosyltransferases - This invention relates to cells with modified blood group antigen expression. In particular, the invention relates to cells for use in haematology, immunohaemotology and immunology assays as serology controls. | 12-22-2011 |